BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 17881443)

  • 1. 7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3G.
    Wang T; Tian C; Zhang W; Luo K; Sarkis PT; Yu L; Liu B; Yu Y; Yu XF
    J Virol; 2007 Dec; 81(23):13112-24. PubMed ID: 17881443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction with 7SL RNA but not with HIV-1 genomic RNA or P bodies is required for APOBEC3F virion packaging.
    Wang T; Tian C; Zhang W; Sarkis PT; Yu XF
    J Mol Biol; 2008 Jan; 375(4):1098-112. PubMed ID: 18067920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promiscuous RNA binding ensures effective encapsidation of APOBEC3 proteins by HIV-1.
    Apolonia L; Schulz R; Curk T; Rocha P; Swanson CM; Schaller T; Ule J; Malim MH
    PLoS Pathog; 2015 Jan; 11(1):e1004609. PubMed ID: 25590131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virion packaging determinants and reverse transcription of SRP RNA in HIV-1 particles.
    Tian C; Wang T; Zhang W; Yu XF
    Nucleic Acids Res; 2007; 35(21):7288-302. PubMed ID: 17959647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of potent human antiviral cytidine deaminases with 7SL RNA and viral RNP in HIV-1 virions.
    Zhang W; Du J; Yu K; Wang T; Yong X; Yu XF
    J Virol; 2010 Dec; 84(24):12903-13. PubMed ID: 20926562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of APOBEC3G binding to 7SL RNA.
    Bach D; Peddi S; Mangeat B; Lakkaraju A; Strub K; Trono D
    Retrovirology; 2008 Jul; 5():54. PubMed ID: 18597676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct viral determinants for the packaging of human cytidine deaminases APOBEC3G and APOBEC3C.
    Wang T; Zhang W; Tian C; Liu B; Yu Y; Ding L; Spearman P; Yu XF
    Virology; 2008 Jul; 377(1):71-9. PubMed ID: 18495196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GANP interacts with APOBEC3G and facilitates its encapsidation into the virions to reduce HIV-1 infectivity.
    Maeda K; Almofty SA; Singh SK; Eid MMA; Shimoda M; Ikeda T; Koito A; Pham P; Goodman MF; Sakaguchi N
    J Immunol; 2013 Dec; 191(12):6030-6039. PubMed ID: 24198285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mov10 and APOBEC3G localization to processing bodies is not required for virion incorporation and antiviral activity.
    Izumi T; Burdick R; Shigemi M; Plisov S; Hu WS; Pathak VK
    J Virol; 2013 Oct; 87(20):11047-62. PubMed ID: 23926332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the contribution of cellular and viral RNA to the packaging of APOBEC3G into HIV-1 virions.
    Khan MA; Goila-Gaur R; Opi S; Miyagi E; Takeuchi H; Kao S; Strebel K
    Retrovirology; 2007 Jul; 4():48. PubMed ID: 17631688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOBEC3G inhibits microRNA-mediated repression of translation by interfering with the interaction between Argonaute-2 and MOV10.
    Liu C; Zhang X; Huang F; Yang B; Li J; Liu B; Luo H; Zhang P; Zhang H
    J Biol Chem; 2012 Aug; 287(35):29373-83. PubMed ID: 22791714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging.
    Luo K; Liu B; Xiao Z; Yu Y; Yu X; Gorelick R; Yu XF
    J Virol; 2004 Nov; 78(21):11841-52. PubMed ID: 15479826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encapsidation of APOBEC3G into HIV-1 virions involves lipid raft association and does not correlate with APOBEC3G oligomerization.
    Khan MA; Goila-Gaur R; Kao S; Miyagi E; Walker RC; Strebel K
    Retrovirology; 2009 Nov; 6():99. PubMed ID: 19886996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOBEC3G encapsidation into HIV-1 virions: which RNA is it?
    Strebel K; Khan MA
    Retrovirology; 2008 Jul; 5():55. PubMed ID: 18597677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOBEC3G complexes decrease human immunodeficiency virus type 1 production.
    Martin KL; Johnson M; D'Aquila RT
    J Virol; 2011 Sep; 85(18):9314-26. PubMed ID: 21752914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC basic linker.
    Burnett A; Spearman P
    J Virol; 2007 May; 81(10):5000-13. PubMed ID: 17344295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular interactions between APOBEC3G, RNA, and HIV-1 Gag: APOBEC3G multimerization is dependent on its association with RNA.
    Friew YN; Boyko V; Hu WS; Pathak VK
    Retrovirology; 2009 Jun; 6():56. PubMed ID: 19497112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1.
    Huthoff H; Autore F; Gallois-Montbrun S; Fraternali F; Malim MH
    PLoS Pathog; 2009 Mar; 5(3):e1000330. PubMed ID: 19266078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 Vif inhibits G to A hypermutations catalyzed by virus-encapsidated APOBEC3G to maintain HIV-1 infectivity.
    Wang Y; Kinlock BL; Shao Q; Turner TM; Liu B
    Retrovirology; 2014 Oct; 11():89. PubMed ID: 25304135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reverse transcriptase- and RNA packaging signal-dependent incorporation of APOBEC3G into hepatitis B virus nucleocapsids.
    Nguyen DH; Hu J
    J Virol; 2008 Jul; 82(14):6852-61. PubMed ID: 18480459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.